Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vance Mccollom"'
Autor:
David Sacks, Sabeen Dhand, Ryan Hegg, Kevin Hirsch, Vance McCollom, Shawn Sarin, Venu Vadlamudi, Thomas Wasser, Christopher Zylak
Publikováno v:
Journal of vascular and interventional radiology : JVIR. 33(6)
To test the hypothesis that interventional radiologists (IRs) and neurointerventional (NI) physicians have similar outcomes of endovascular stroke thrombectomy (EVT), which could be used to improve the availability of thrombectomy.Eight hospitals pro
Autor:
Joan C. Wojak, Venu Vadlamudi, Mark O. Baerlocher, Martin G. Radvany, Joseph J. Gemmete, Vance McCollom, P. Brady, Mazen K. AbuAwad, David Sacks, Sun Ho Ahn, Sabeen Dhand, John W. Cole, Michael S. Webb, Benjamin D. Fox, Parag J. Patel, Joanna Kee-Sampson, Robert D. Tomalty
Publikováno v:
Journal of Vascular and Interventional Radiology. 30:1523-1531
Autor:
David B. Sacks, Sabeen Dhand, Christopher Zylak, Kevin Hirsch, Shawn Sarin, Vance McCollom, Ryan Hegg, Venu Vadlamudi
Publikováno v:
Stroke. 51
Introduction: Endovascular stroke treatment (EVT) may be provided by physicians with varying specialty training. It is possible that physicians without dedicated neurointerventional training will have outcomes inferior to physicians with such dedicat
Autor:
Joseph A. Andrezik, Thomas S. Griggs, Jeffrey G. Belisle, Vance McCollom, J. Mike Banowetz, Timothy L. Tytle, Robert A. Handley
Publikováno v:
Journal of Vascular and Interventional Radiology. 20:327-333
Purpose To determine the safety and feasibility of intraarterial stroke therapy for acute ischemic strokes at a community-based medical center. Materials and Methods This is a retrospective analysis of data gathered from consecutive stroke patients t
Autor:
Michael K. Schaufele, John M. Mathis, Vance Mccollom, Ramsin Benyamin, Homer Paul Hatten, Maarten Persenaire, Louis A. Gilula, A. David Tahernia, Philip Maurer, Hyun W. Bae, Raymond Linovitz
Publikováno v:
Spine. 37(7)
Study Design. Randomized, controlled, prospective (AAOS therapeutic level I) trial conducted under Food and Drug Administration Investigational Device Exemption hypothesized noninferiority of a novel bioactive composite material to polymethylmethacry